A 32-year-old multiparous woman (G3P2) undergoes emergency cesarean section at 38 weeks for placenta previa. Intraoperatively, the lower uterine segment is thin and friable. The placenta is removed with difficulty, and the surgeon notes a small area of myometrial invasion at the placental bed. Estimated blood loss is 1200 mL. In the recovery room, 2 hours postoperatively, the patient has continuous vaginal oozing. Vitals: BP 95/58 mmHg, HR 118/min, RR 24/min. Hemoglobin is 8.5 g/dL (down from 10.8 g/dL preoperatively). Uterus is firm on palpation. What is the most likely diagnosis?

Explanation

## Diagnosis: Placenta Accreta with Incomplete Hemostasis This case presents a high-risk scenario for morbidly adherent placenta (MAP), with clinical and surgical findings consistent with placenta accreta. ### Risk Factors Present | Risk Factor | Present in This Case? | Significance | |---|---|---| | **Placenta previa** | Yes | Major risk factor; increases MAP risk 10-fold | | **Multiparity** | Yes (G3P2) | Each prior delivery increases risk | | **Prior cesarean** | Implied (P2) | Uterine scar provides substrate for abnormal invasion | | **Thin, friable lower segment** | Yes | Suggests thinned myometrium from prior surgery | | **Difficult placental removal** | Yes | Suggests abnormal adherence | | **Visible myometrial invasion** | Yes | Surgeon's direct observation of accreta | **Key Point:** The **combination of placenta previa + prior cesarean + intraoperative difficulty with placental removal** is pathognomonic for morbidly adherent placenta. ### Why This Is NOT Uterine Atony (Option A) ```mermaid flowchart TD A[Postoperative Hemorrhage]:::outcome --> B{Uterine Consistency?}:::decision B -->|Soft/Boggy| C[Uterine Atony]:::outcome B -->|Firm| D[Atony Unlikely]:::action D --> E{Risk factors for MAP?}:::decision E -->|Yes: previa + prior CS| F[Placenta Accreta]:::outcome E -->|No| G[Coagulopathy or Trauma]:::outcome F --> H[Inadequate hemostasis at bed]:::action C --> I[Oxytocin/Ergot/Misoprostol]:::action H --> J[Reexploration ± interventional radiology]:::action ``` **Clinical Pearl:** A **firm uterus rules out atony**. Atony presents with a soft, boggy, distended uterus. This patient's firm uterus indicates the problem is NOT inadequate contraction but rather **incomplete hemostasis at the placental bed**—a hallmark of accreta. ### Pathophysiology of Placenta Accreta Hemorrhage 1. **Abnormal trophoblastic invasion** penetrates myometrium (partial or complete) 2. **Placental villi invade directly into myometrial vessels** (no intervening decidua) 3. **Placental separation** tears open maternal blood vessels without the normal protective layer of decidualized endometrium 4. **Bleeding from myometrial vessels** cannot be controlled by uterine contraction alone because the vessels are **within or beneath the myometrium**, not in the placental bed surface 5. **Result:** Continuous oozing despite a firm, contracting uterus **High-Yield:** In accreta, the bleeding source is **deep myometrial vessels**, not the placental bed surface. Oxytocin-induced contraction compresses superficial vessels but cannot occlude deep myometrial bleeding. ### Why Coagulopathy Is Less Likely (Option C) - **Hemoglobin drop of 2.3 g/dL** from a 1200 mL blood loss is proportionate (expected ~2 g/dL drop per 1 L loss in a 70 kg woman) - **No mention of oozing from other sites** (wound, IV sites, mucous membranes) - **Coagulopathy typically presents with diffuse bleeding**, not localized vaginal oozing - **Timing:** Coagulopathy from massive transfusion usually develops after >4 units PRBC; patient is only 2 hours postop ### Why Uterine Rupture Is Unlikely (Option D) - **Rupture would present with intra-abdominal hemorrhage**, not vaginal oozing - **Vital signs show hypovolemia but patient is conscious and alert** (no signs of hemorrhagic shock) - **Surgeon would have noted rupture during cesarean closure** - **Rupture is rare after planned cesarean** (risk ~0.3%); more common after VBAC ### Management of Accreta-Related PPH 1. **Immediate:** Aggressive IV fluid resuscitation, activate massive transfusion protocol 2. **Surgical:** Reexploration to identify bleeding source; consider: - Oversewing of bleeding vessels - Hysterectomy (definitive if bleeding uncontrolled and fertility not desired) 3. **Interventional:** Uterine artery embolization (UAE) or balloon occlusion if available and patient stable enough for transfer 4. **Medical:** Oxytocin, ergot alkaloids, misoprostol (adjunctive only; will not stop myometrial bleeding) **Clinical Pearl:** Antenatal diagnosis of suspected MAP allows for planned cesarean in a tertiary center with OR, blood bank, and IR support. Intraoperative recognition (as in this case) mandates immediate senior involvement and preparation for hysterectomy. ## Summary The **firm uterus + placenta previa + prior cesarean + intraoperative difficulty with placental removal + continuous oozing despite firm contraction** all point to **placenta accreta with incomplete hemostasis at the myometrial bed**. This requires urgent reexploration and likely hysterectomy, not medical management of atony.